Canada markets open in 51 minutes

Zentalis Pharmaceuticals, Inc. (ZNTL)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
11.42+0.36 (+3.25%)
At close: 04:00PM EDT
11.42 0.00 (0.00%)
After hours: 04:06PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
189,590
189,590
172,734
175,601
84,901
Selling General and Administrative
64,351
64,351
54,553
40,941
33,886
Total Operating Expenses
253,941
253,941
227,287
216,542
118,787
Operating Income or Loss
-253,941
-253,941
-227,287
-216,542
-118,787
Total Other Income/Expenses Net
-22,951
-22,951
5,987
51,983
683
Income Before Tax
-276,892
-276,892
-221,300
-164,559
-118,104
Income Tax Expense
-601
-601
-469
-297
444
Income from Continuing Operations
-292,305
-292,305
-237,113
-166,093
-118,548
Net Income
-292,191
-292,191
-236,806
-158,725
-117,841
Net Income available to common shareholders
-292,191
-292,191
-236,806
-158,725
-117,841
Basic EPS
-4.56
-
-4.48
-3.72
-4.19
Diluted EPS
-4.56
-
-4.48
-3.72
-4.19
Basic Average Shares
62,234
-
52,857
42,688
28,113
Diluted Average Shares
62,234
-
52,857
42,688
28,113